DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

Stop Worrying About Ebola: This is a Much More Pressing Concern

Ebola may be garnering all of the headlines, but this infectious disease has been a contributing factor to the eighth leading cause of death in the U.S.

Is It Time To Shift Into European Equities?

Merck Collaboration Rules Out AstraZeneca Acquisition--For Now

Pfizer/Merck KGaA Immune Checkpoint Deal Bodes Extremely Well For Compugen

ISIS-STAT3 Rx And ISIS-AR Rx Data Presented By AstraZeneca At European Cancer Symposium

Sanofi Beats The Drum

What Does The U.S. Dollar Bull Market Mean For European Equities?

Astrazeneca (AZN) Downgraded From Buy to Hold

The Crucial Thing You're Missing About Many Dividend Stocks

In this edition of "Where the Money Is," one Motley Fool contributor explains why the earnings payout ratio isn't the ratio dividend investors should actually be watching.

AstraZeneca Targets More than $45B in Revenues in 2023 - Analyst Blog

See More Articles...